Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C - PubMed (original) (raw)
Comparative Study
doi: 10.1002/hep.21103.
Colin Banas, Carol Sargeant, Velimir A Luketic, Richard K Sterling, Richard T Stravitz, Mitchell L Shiffman, Douglas Heuman, Adrian Coterrell, Robert A Fisher, Melissa J Contos, Alan S Mills
Affiliations
- PMID: 16502396
- DOI: 10.1002/hep.21103
Comparative Study
Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C
Arun J Sanyal et al. Hepatology. 2006 Apr.
Abstract
The objective of this study was to prospectively define outcomes of cirrhosis due to nonalcoholic steatohepatitis (NASH) and compare them with those associated with hepatitis C virus (HCV) infection. We compared 152 patients with cirrhosis due to NASH with 150 matched patients with cirrhosis due to HCV. Over 10 years, 29/152 patients with cirrhosis due to NASH died compared with 44/150 patients with HCV (P < .04). This was mainly due to the lower mortality rate in patients with Child class A cirrhosis due to NASH versus HCV (3/74 vs. 15/75; P < .004). There were no significant across-group differences in mortality in patients with Child class B or C cirrhosis. Sepsis was the most common cause of death in both groups; patients with NASH had a higher cardiac mortality (8/152 vs. 1/150; P < .03). Patients with Child class A cirrhosis due to NASH also had a significantly lower risk of decompensation, defined by a 2-point increase in Child-Turcotte-Pugh score (P < .007). Cirrhosis due to NASH was associated with a lower rate of development of ascites (14/101 vs. 40/97 patients at risk; P < .006). NASH also had a significantly lower risk of development of hepatocellular carcinoma (10/149 vs. 25/147 patients at risk; P < .01). In conclusion, compensated cirrhosis due to NASH is associated with a lower mortality rate compared with that due to HCV. It is also associated with a lower rate of development of ascites, hyperbilirubinemia, and hepatocellular carcinoma. However, cardiovascular mortality is greater in patients with NASH.
Similar articles
- Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
Bhagat V, Mindikoglu AL, Nudo CG, Schiff ER, Tzakis A, Regev A. Bhagat V, et al. Liver Transpl. 2009 Dec;15(12):1814-20. doi: 10.1002/lt.21927. Liver Transpl. 2009. PMID: 19938128 - Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.
Hui JM, Kench JG, Chitturi S, Sud A, Farrell GC, Byth K, Hall P, Khan M, George J. Hui JM, et al. Hepatology. 2003 Aug;38(2):420-7. doi: 10.1053/jhep.2003.50320. Hepatology. 2003. PMID: 12883486 - Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma.
Malik SM, Gupte PA, de Vera ME, Ahmad J. Malik SM, et al. Clin Gastroenterol Hepatol. 2009 Jul;7(7):800-6. doi: 10.1016/j.cgh.2009.02.025. Epub 2009 Mar 9. Clin Gastroenterol Hepatol. 2009. PMID: 19281869 - Etiological factor of hepatocellular carcinoma in Italy.
Stroffolini T. Stroffolini T. Minerva Gastroenterol Dietol. 2005 Mar;51(1):1-5. Minerva Gastroenterol Dietol. 2005. PMID: 15756142 Review. - Management of HCV-related end-stage liver disease in HIV-coinfected patients.
Merchante N, Jiménez-Saenz M, Pineda JA. Merchante N, et al. AIDS Rev. 2007 Jul-Sep;9(3):131-9. AIDS Rev. 2007. PMID: 17982938 Review.
Cited by
- Hard clinical outcomes in patients with NAFLD.
Kumar R. Kumar R. Hepatol Int. 2013 Dec;7 Suppl 2:790-9. doi: 10.1007/s12072-013-9455-y. Epub 2013 Aug 6. Hepatol Int. 2013. PMID: 26202293 - Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies.
Oda K, Uto H, Mawatari S, Ido A. Oda K, et al. Clin J Gastroenterol. 2015 Feb;8(1):1-9. doi: 10.1007/s12328-014-0548-5. Epub 2015 Jan 10. Clin J Gastroenterol. 2015. PMID: 25575848 Review. - Multi-SNP analysis of GWAS data identifies pathways associated with nonalcoholic fatty liver disease.
Chen QR, Braun R, Hu Y, Yan C, Brunt EM, Meerzaman D, Sanyal AJ, Buetow K. Chen QR, et al. PLoS One. 2013 Jul 19;8(7):e65982. doi: 10.1371/journal.pone.0065982. Print 2013. PLoS One. 2013. PMID: 23894275 Free PMC article. - Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis.
Wildman-Tobriner B, Middleton MM, Moylan CA, Rossi S, Flores O, Chang ZA, Abdelmalek MF, Sirlin CB, Bashir MR. Wildman-Tobriner B, et al. Gastroenterology. 2018 Nov;155(5):1428-1435.e2. doi: 10.1053/j.gastro.2018.07.018. Epub 2018 Jul 19. Gastroenterology. 2018. PMID: 30031769 Free PMC article. - World Congress on the Insulin Resistance Syndrome, 2009: the kidney, the liver, and insulin resistance.
Bloomgarden ZT. Bloomgarden ZT. Diabetes Care. 2010 Sep;33(9):e116-20. doi: 10.2337/dc10-zb09. Diabetes Care. 2010. PMID: 20805262 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical